From formation through liquidity, IP is a key value driver for healthtech companies. Now is not the time to give it short shrift. Our panel of executives, investors and experienced IP practitioners will share strategies to reduce near-term spend and preserve long-term value.

Discussion topics will address:

• Portfolio strategy considerations and prioritizing spend
• Creative strategies to manage IP timeline and related filing expenses
• Hone-in on critical IP issues relevant to fundraising, commercialization and potential partnerships/acquisitions
• Cost-effective IP strategies to mitigate risk from third parties

Learn more about the speakers and register today.